TrialDiabetes, obesity & metabolism2018

Semaglutide induces weight loss in subjects with type 2 diabetes regardless of baseline BMI or gastrointestinal adverse events in the SUSTAIN 1 to 5 trials.

Bo Ahrén et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.